Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India https://ift.tt/7beW3w9

Bempedoic Acid has a new mechanism of action compared to existing products. It is administered as a 180-mg dose, is approved by the US FDA and European Union for the treatment of hypercholesterolemia.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/BJ7xzbA
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.